• Products
  • Suppliers
  • Sourcing Requests
Post Sourcing Request Exhibition
  • Array BioPharma’s mCRC therapy gets breakthrough status pharmaceutical-technology
    August 10, 2018
    Array BioPharma has received breakthrough therapy designation from the US Food and Drug Administration (FDA) to use encorafenib (Braftovi) in combination with binimetinib (Mektovi) and cetuximab for the treatment of metastatic colorectal cancer (mCRC).

Contact Us

PharmaSources@imsinoexpo.com

Tel: (+86) 400 610 1188

WhatsApp/Telegram/Wechat: +86 13621645194

About Us
About PharmaSources
Terms of Service
Privacy Policy
Event Data Sharing Notice
Intellectual Property
Media Partners
Buy
Search Products
Post Sourcing Requests
Search Suppliers
CAS Search
Sell
Member Application
Advertising
Post Products
EZSourcing
Events
CPHI China
PMEC China
Conferences
Search Events
Help
FAQ
Contact Us
Feedback
PharmaSources Customer Service